Job Trends
BioSpace data show job postings live increased quarter over quarter, while layoffs fell year over year.
Labor Market Reports
BioSpace’s 2026 U.S. Life Sciences Employment Outlook examines the state of the biopharma workforce amid ongoing funding pressure, elevated layoffs and cautious hiring sentiment, while highlighting early signals of stabilization and cautious optimism for the year ahead.
BioSpace’s 2025 Q4 U.S. Life Sciences Job Market update highlights early signs of stabilization in biopharma hiring, with modest gains in job postings, slowing layoffs, and cautiously improving sentiment heading into 2026.
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
Now Hiring
Looking for an IT job? From data engineer to information security, check out the BioSpace list of 10 companies hiring life sciences professionals like you.
More biopharma organizations were actively recruiting at the end of 2025 than 2024, based on the new BioSpace employment outlook report. Areas in demand this year include research and development and clinical. Organizations are also prioritizing artificial intelligence hires.
Looking for a research and development job? Check out the BioSpace list of 12 companies hiring life sciences professionals like you.
Career Advice
If workloads aren’t adjusted as needed, the company’s priorities are already compromised. Executive coach Angela Justice explores what happens when goals move forward without removing unnecessary work and what to do about it.
THE LATEST
A single cholesterol-derived molecule, called 27-hydroxycholesterol (27HC), lurks inside your bloodstream and will increase your body fat, even if you don’t eat a diet filled with red meat and fried food. That kind of diet, however, will increase the levels of 27HC and body weight.
MassBio recently published their annual “2019 Industry Snapshot.” In addition to providing an in-depth look at the industry in the state, it provides a wealth of data on the industry overall.
Kalos Therapeutics has engaged with The OCMX to assist in fund raising.
Between J&J, Purdue ($270 million), and Israel-based Teva Pharmaceuticals ($85 million), Oklahoma will garner about $927 million – a far cry from the $20 billion the state had been seeking in damages related to the opioid crisis.
Denver Health Foundation has been awarded a grant from The Gerber Foundation to fund a research project, the NO TEARS study, looking at ear infections, the most common childhood infection.
Study will evaluate outcomes from integrating oral health care with community health center services
More Women May Benefit from Hereditary Cancer Risk Assessment and Genetic Testing
rfxcel, the global leader in supply chain track and trace solutions, will exhibit at this year’s CPhI Middle East & Africa conference in Abu Dhabi, United Arab Emirates.
The National Institutes of Health has awarded Fannin Innovation Studio® a $1 million grant to continue development of PM-43I, the company’s anti-asthma drug, in collaboration with portfolio company Atrapos Therapeutics, LLC., as a more effective alternative to steroids.
“This investment will further strengthen Pfizer’s leadership in gene therapy manufacturing technology,” stated Mike McDermott, president, Pfizer Global Supply.